PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 2016. Start Trial.
Date Value
November 16, 2026 9.566
November 13, 2026 9.285
November 12, 2026 8.811
November 11, 2026 9.145
November 10, 2026 8.802
November 09, 2026 8.601
November 06, 2026 7.539
November 05, 2026 7.012
November 04, 2026 7.916
November 03, 2026 7.776
November 02, 2026 7.881
October 30, 2026 8.346
October 29, 2026 8.557
October 28, 2026 8.197
October 27, 2026 7.311
October 26, 2026 6.565
October 23, 2026 6.591
October 22, 2026 6.494
October 21, 2026 6.995
October 20, 2026 7.205
October 19, 2026 7.034
October 16, 2026 6.819
October 15, 2026 7.223
October 14, 2026 7.109
October 13, 2026 7.828
Date Value
October 12, 2026 8.109
October 09, 2026 7.881
October 08, 2026 7.916
October 07, 2026 8.039
October 06, 2026 8.741
October 05, 2026 9.048
October 02, 2026 8.671
October 01, 2026 8.741
September 30, 2026 8.925
September 29, 2026 9.828
September 28, 2026 9.622
September 25, 2026 9.779
September 24, 2026 10.11
September 23, 2026 9.754
September 22, 2026 9.838
September 21, 2026 9.564
September 18, 2026 9.368
September 17, 2026 9.221
September 16, 2026 8.860
September 15, 2026 8.684
September 14, 2026 8.644
September 11, 2026 8.517
September 10, 2026 8.596
September 09, 2026 8.527
September 08, 2026 9.124

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Axogen, Inc. 11.06
Tandem Diabetes Care, Inc. 1.089
Accuray, Inc. 0.0194
Orthofix Medical, Inc. 0.3249
ResMed, Inc. 6.027

PS Ratio Related Metrics

PEG Ratio -0.0571
Price to Book Value 7.177
Price 10.17
Earnings Yield -23.03%
Market Cap 557.07M
PEGY Ratio -0.0571